Transcatheter Mitral Valve Implantation (TMVI) Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Apr 16, 2023

Dublin, May 17, 2023 (GLOBE NEWSWIRE) -- The "Transcatheter Mitral Valve Implantation (TMVI) Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.The publisher's Medical Devices sector report provides comprehensive information about the Transcatheter Mitral Valve Implantation (TMVI) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.The Transcatheter Heart Valve is a artificial heart valve made up of natural tissue (biological material mainly derived from cow or bovine) surrounded by a flexible mesh frame known as stent (made of steel or cobalt-chromium), all placed in a long narrow tube known as a catheter.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.Scope

Extensive coverage of the Transcatheter Mitral Valve Implantation (TMVI) under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Transcatheter Mitral Valve Implantation (TMVI) and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment/industry

Reasons to Buy The report enables you to:

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Transcatheter Mitral Valve Implantation (TMVI) under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered: 1 Table of Contents 2 Introduction2.1 Transcatheter Mitral Valve Implantation (TMVI) Overview3 Products under Development3.1 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development3.2 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory3.3 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path3.4 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date3.5 Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials4 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products under Development by Companies4.1 Transcatheter Mitral Valve Implantation (TMVI) Companies - Pipeline Products by Stage of Development4.2 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development5 Transcatheter Mitral Valve Implantation (TMVI) Companies and Product Overview5.1 4C Medical Technologies Inc Company Overview5.1.1 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview5.2 Abbott Vascular Inc Company Overview5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview5.3 Annulon Company Overview5.3.1 Annulon Pipeline Products & Ongoing Clinical Trials Overview5.4 Cardiovalve Ltd Company Overview5.4.1 Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview5.5 Cephea Valve Technologies, Inc. Company Overview5.5.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview5.6 Colibri Heart Valve LLC Company Overview5.6.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview5.7 Direct Flow Medical Inc (Inactive) Company Overview5.7.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview5.8 Edwards Lifesciences Corp Company Overview5.8.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview5.9 Emory University Company Overview5.9.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview5.10 Foldax Inc Company Overview5.10.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview5.11 Jenscare Scientific Co Ltd Company Overview5.11.1 Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview5.12 Jiangsu Zhenyi Medical Technology Co Ltd Company Overview5.12.1 Jiangsu Zhenyi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview5.13 Lepu Medical Technology (Beijing) Co Ltd Company Overview5.13.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview5.14 LivaNova PLC Company Overview5.14.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview5.15 Medtronic Plc Company Overview5.15.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview5.16 Micro Interventional Devices, Inc. Company Overview5.16.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview5.17 MicroPort CardioFlow Medtech Corp Company Overview5.17.1 MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview5.18 MicroPort Scientific Corp Company Overview5.18.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview5.19 MitrAssist Ltd. Company Overview5.19.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview5.20 MValve Technologies Ltd. Company Overview5.20.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview5.21 Neovasc Inc Company Overview5.21.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview5.22 NewMed Medical Co Ltd Company Overview5.22.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview5.23 P+F Products + Features GmbH Company Overview5.23.1 P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview5.24 Polares Medical SA Company Overview5.24.1 Polares Medical SA Pipeline Products & Ongoing Clinical Trials Overview5.25 Shanghai Shenqi Medical Technology Co Ltd Company Overview5.25.1 Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview5.26 Sino Medical Sciences Technology Inc Company Overview5.26.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview5.27 Symetis SA Company Overview5.27.1 Symetis SA Pipeline Products & Ongoing Clinical Trials Overview5.28 Tioga Medical Inc Company Overview5.28.1 Tioga Medical Inc Pipeline Products & Ongoing Clinical Trials Overview5.29 Trinity College Dublin Company Overview5.29.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview5.30 University College London Company Overview5.30.1 University College London Pipeline Products & Ongoing Clinical Trials Overview5.31 Valcare Medical Company Overview5.31.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview5.32 Venus Medtech Hangzhou Inc Company Overview5.32.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview6 Transcatheter Mitral Valve Implantation (TMVI)- Recent Developments 7 Appendix7.1 Methodology7.2 About the Publisher7.3 Contact the Publisher7.4 DisclaimerA selection of companies mentioned in this report includes

4C Medical Technologies Inc

Abbott Vascular Inc

Annulon

Cardiovalve Ltd

Cephea Valve Technologies, Inc.

Colibri Heart Valve LLC

Direct Flow Medical Inc (Inactive)

Edwards Lifesciences Corp

Emory University

Foldax Inc

Jenscare Scientific Co Ltd

Jiangsu Zhenyi Medical Technology Co Ltd

Lepu Medical Technology (Beijing) Co Ltd

LivaNova PLC

Medtronic Plc

Micro Interventional Devices, Inc.

MicroPort CardioFlow Medtech Corp

MicroPort Scientific Corp

MitrAssist Ltd.

MValve Technologies Ltd.

Neovasc Inc

NewMed Medical Co Ltd

P+F Products + Features GmbH

Polares Medical SA

Shanghai Shenqi Medical Technology Co Ltd

Sino Medical Sciences Technology Inc

Symetis SA

Tioga Medical Inc

Trinity College Dublin

University College London

Valcare Medical

Venus Medtech Hangzhou Inc

For more information about this report visit https://www.researchandmarkets.com/r/dtgfixSource: GlobalData

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.